|Articles|May 1, 2001

Artherosclerosis: Achieving Optimal Outcomes in Statin Therapy
Volume 7
Issue 5 Suppl

Surrogate Endpoints and Newer Risk Markers in Atherosclerosis Management

Author(s)Christie M. Ballantyne, MD

Download PDF: Surrogate Endpoints and Newer Risk Markers in Atherosclerosis Management

Articles in this issue

almost 25 years ago

Article

Participating Faculty

almost 25 years ago

Article

Introduction

almost 25 years ago

Article

Should All Patients with Cardiovascular Disease Receive Statin Therapy?

almost 25 years ago

Article

Threshold Level or Not for Low-Density Lipoprotein Cholesterol

almost 25 years ago

Article

Statins--Differences and Similarities

almost 25 years ago

Article

What Do the Statin Trials Tell Us?

almost 25 years ago

Article

New Therapies on the Horizon

almost 25 years ago

Article

A New Statin: A New Standard

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

ByNate C. Apathy, PhD

January 27th 2026

Building Trust: Public Priorities for Health Care AI Labeling

ByMorgan L. Sielaff, BS,Jodyn Platt, PhD, MPH,Sean Tan, MPP,Kerry A. Ryan, MA,Paige Nong, PhD,Sharon L. R. Kardia, PhD

January 27th 2026

Ambient AI Tool Adoption in US Hospitals and Associated Factors

ByFreddie Yang, MA,Ilana Graetz, PhD

January 27th 2026

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

ByTaylor I. Bucy, PhD,John P. McHugh, PhD,Dori A. Cross, PhD

January 26th 2026

Specialty and Operator Status Influence Electronic Health Record Use Variation

ByPhillip D. Jenkins, MD,Gary Grunkemeier, PhD,Elizabeth Weirich, DO,An Dinh, MS,Ruchi Thanawala, MD, MS,Jeffrey A. Gold, MD,Julie Doberne, MD, PhD

January 22nd 2026

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

Surrogate Endpoints and Newer Risk Markers in Atherosclerosis Management

Articles in this issue

Newsletter

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

Specialty and Operator Status Influence Electronic Health Record Use Variation

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Trending on AJMC

FDA Flags Administration Concerns for Aquestive's Noninvasive Epinephrine Film

Prior Authorization Ranked Top Barrier to Health Care Access After Cost

Contributor: The Majority (57.5%) of Commercially Insured Patients Had 1 or More Chronic Conditions in 2024

Pulmonary Fibrosis and Sexual Health: A Q&A With Na’ama Avitzur, MD

FAQs About Glaucoma as Awareness Month Concludes